---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-026875"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2022-12-21T23:59:59+00:00"
generated_at: "2026-06-21T00:49:59.458301+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Corbus shareholders approve reverse stock split at ratio up to 1:40

## Summary
- Shareholders approved amendment to authorize reverse split from 1:4 to 1:40, board to set exact ratio.
- Adjournment proposal also approved; both items passed at special meeting on Dec 20, 2022.
- Record date for voting was Nov 7, 2022, with 125,280,881 common shares outstanding.
- Final vote on reverse split: 25.79 trillion for, 5.06 trillion against, 0.47 trillion abstentions.
- Reverse split intended to meet Nasdaq listing requirements and raise per-share price.

## SEC filing metadata
- accession: 0000950170-22-026875
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2022-12-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017022026875/0000950170-22-026875-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017022026875/crbp-20221220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-026875
- JSON: https://secwatch.observer/filing/0000950170-22-026875.json
- Plain text: https://secwatch.observer/filing/0000950170-22-026875.txt

## Key facts
- Shareholder Votes
  Corbus Pharmaceuticals Holdings, Inc. shareholders approved Adoption and approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of common stock at a ratio from 1:4 to 1:40 at the 2022-12-20 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2022-12-20
  source text: 1. The Reverse Stock Split Proposal. The votes were cast for this matter as follows: Votes For Votes Against Abstentions 25,794,110,289,993 5,064,240,621,803 474,524,757,330
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595097/000095017022026875/0000950170-22-026875-index.htm
- Shareholder Votes
  Corbus Pharmaceuticals Holdings, Inc. shareholders approved Approval of the adjournment of the Special Meeting to the extent there are insufficient votes to approve the Reverse Stock Split Proposal at the 2022-12-20 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2022-12-20
  source text: 2. The Adjournment Proposal. The votes were cast for this matter as follows: Votes For Votes Against Abstentions 51,281,428 10,784,629 603,069
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595097/000095017022026875/0000950170-22-026875-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.